Prognostic factors for non‐cleaved follicular center‐cell lymphomas and immunoblastic sarcoma A Bayesian approach
- 1 May 1984
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 32 (5) , 475-487
- https://doi.org/10.1111/j.1600-0609.1984.tb02188.x
Abstract
The Bayesian multivariate statistical method was applied to determine the relative strength and optimal combination of 17 variables in predicting the survival of 151 patients with non-Hodgkin''s lymphomas, assigned as non-cleaved follicular center-cell and immunoblastic sarcoma types. Considering all the factors simultaneously, the analysis showed that the combination of stage, Hb level and location of the lymphoma was included in the best predictive model at each survival time studied. Additional factors were erythrocyte sedimentation rate, thrombocyte count and leukocyte count. Of the histological variables, only growth pattern and mitotic ratio in the biopsy specimen remained significant. At manually controlled computer simulation with these best indicators, this model would have given a correct classification for 69-78% of the patients at the 4 survival times studied. One can expect about 70% correct prognoses using this model.Keywords
This publication has 51 references indexed in Scilit:
- Concordance of the Kiel and Lukes‐Collins classifications of non‐Hodgkin's lymphomasHistopathology, 1983
- LymphopeniaScandinavian Journal of Haematology, 1982
- The impact of growth pattern on survival in non-Hodgkin's lymphomas classified according to Lukes and CollinsPathology - Research and Practice, 1982
- Indications for and morbidity associated with operative staging in patients with lymphomaThe American Journal of Surgery, 1982
- Clinico-Pathologic Correlation in Non-Hodgkin's Lymphoma: II. Clinical and prognostic significance of nodularityActa Radiologica: Oncology, Radiation, Physics, Biology, 1979
- Clinico-Pathologic Correlation in non-Hodgkin's Lymphoma: I. Retrospective analysis using the Lukes and Collins classificationActa Radiologica: Oncology, Radiation, Physics, Biology, 1979
- Clinical Relevance of the Histopathological Subclassification of Diffuse “Histiocytic” LymphomaNew England Journal of Medicine, 1978
- Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapyThe American Journal of Medicine, 1977
- American Burkitt's lymphoma: A clinicopathologic study of 30 casesThe American Journal of Medicine, 1975
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASEThe Lancet, 1975